| Roderick W Fontenette, MD | |
|
101 Bodin Cir, Central Credentialing, Travis Afb, CA 94535-1809 | |
| (707) 423-3000 | |
| Not Available |
| Full Name | Roderick W Fontenette |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 101 Bodin Cir, Travis Afb, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164672499 | NPI | - | NPPES |
| 201021810 | Medicaid | IN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health St Helena | Saint helena, CA | Hospital |
| University Of California Davis Medical Center | Sacramento, CA | Hospital |
| Sutter Roseville Medical Center | Roseville, CA | Hospital |
| Adventist Health Ukiah Valley | Ukiah, CA | Hospital |
| Adventist Health Clearlake | Clearlake, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The Univ Of Ca | 3375456619 | 1346 |
| Inpatient Specialists Of California Pc | 3476864448 | 289 |
| Cep America - California | 6103739131 | 954 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Entity Name | Regents Of The Univ Of Ca |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013906973 PECOS PAC ID: 3375456619 Enrollment ID: O20031111000892 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Entity Name | San Francisco Physicians International Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841220720 PECOS PAC ID: 5597679225 Enrollment ID: O20031117000934 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Entity Name | Inpatient Specialists Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952792475 PECOS PAC ID: 3476864448 Enrollment ID: O20150617000915 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Entity Name | Pura Vida Recovery Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346786696 PECOS PAC ID: 5193178283 Enrollment ID: O20240124004742 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roderick W Fontenette, MD 101 Bodin Cir, Central Credentialing, Travis Afb, CA 94535-1809 Ph: (707) 423-3000 | Roderick W Fontenette, MD 101 Bodin Cir, Central Credentialing, Travis Afb, CA 94535-1809 Ph: (707) 423-3000 |
News Archive
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have identified that injection frequency and taking anti-retroviral therapy for HIV are risk factors for nonfatal drug overdoses among Russians who are HIV positive and inject drugs.
Dengue fever is a major public health concern in many parts of South-East Asia and South America and its prevalence in Africa is thought to be expanding. Researchers have now conducted an analysis of the economic burden of dengue fever in Burkina Faso, Kenya and Cambodia.
To be sure, some progress has been made the past two years. Policymakers have enacted about $2.7 trillion in deficit reduction, primarily through cuts in discretionary spending and higher taxes on wealthy individuals. Yet what we have achieved so far is insufficient.
People with multiple sclerosis (MS) lose myelin in the gray matter of their brains and the loss is closely correlated with the severity of the disease, according to a new magnetic resonance imaging (MRI) study.
› Verified 1 days ago
Dr. Andrew James Amack, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3825 | |
Douglas Alfar, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3825 | |
Dr. Jacob Andrew Binder, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3826 | |
Alexa Marie Gingras, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3825 | |
Carol Knight, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 954-682-3481 | |
Dr. Nurani Michael Kester, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3826 Fax: 707-423-7204 |